Use of toxicokinetic and toxicodynamic data to reduce uncertainties when setting occupational exposure limits for pharmaceuticals

Human and Ecological Risk Assessment (HERA)

Volumn 3, Issue 4, 1997, Pages 555-565

  Naumann, Brace D ^a   Weideman, Patricia A ^a,b   Dixit, Rakesh ^a   Grossman, Scott J ^a   Frank Shen, C ^a,c   Sargent, Edward V ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b DUPONT COMPANY   (United States)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Acceptable daily intake; Pharmacodynamic; Pharmacokinetic; Uncertainty factors

Indexed keywords

EID: 21944454985     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807039709383711     Document Type: Article

References (12)

1. REFERENCES Baird, J.S.S., Cohen,J.T., Graham,J.D., Shlyakhter, A.I., and Evans J.S. 1996. Noncancer risk assessment: A probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 2, 1, 79-102.
2. Barnes, D.G. and Dourson, M. 1988. Reference Dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol., 8, 471-486.
3. Crump, K.S. 1984. A new method for determining allowable daily intakes. Fund. Appl. Toxicol, 4, 854-871.
4. Crump, K.S. 1995. Calculation of benchmark doses from continuous data. Risk Anal. 15, 1, 79-89.
5. Davies, R.O. 1979. Review of pharmacokinetics and bioavailability of timolol in man. Proceedings of the Timolol Intercontinental Symposium held in Stockholm, Sweden, October 27-28, 1979.
6. Hattis, D., Erdreich, L. and Ballew, M. 1987. Human variability in susceptibility to toxic chemicals - a preliminary analysis of pharmaceutical data from normal volunteers. Risk Anal. 7, 4, 415-426.
7. IPCS (International Programme on Chemical Safety) 1994. Assessing human health risks of chemicals: The derivation of guidance values for health-based exposure limits. Environmental Health Criteria 170. Geneva, World Health Organization.
8. McGourty, J.C., Silas, J.H., Fleming, J.J., McBurney, A., Phil, M. and Ward, J.W. 1985. Pharmacokinetics of beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin. Clin. Pharmacol. Ther. 38, 409-413.
9. Naumann, B.D. and Weideman, P.A. 1996. Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients. Hum. Ecol. Risk Assess. 1, 5, 590-613.
10. Renwick, A.G. 1993. Data-derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit. Contamin., 10, 3, 275-305.
11. Sargent, E. V. and Kirk, G. D. 1988. Establishing airborne exposure control limits in the pharmaceutical industry. Am. Ind. Hyg. Assoc. J., 49, 6, 309-313.
12. Swartout. J.C., Keenean, R.E., Stickney, J.A., Gillis, C.A., Carlson-Lynch, H.L., Dourson, M.L., Harvey, T. and Price, P.S. 1997. A probabilistic framework for the reference dose. Fund. Appl. Toxicol. (Suppl) 36, 1, 2, 208.